Inhibiting NNMT Expression Lowering the expression of the NNMT enzyme isnt anything new under the sun, as it is well-connected to several disease states: NNMT is implicated in various disease conditions such as metabolic disorders, neurodegenerative diseases and cancer, and tissue NNMT expression or plasma levels of its product MNA have been proposed as biomarkers for these conditions Other chronic metabolic diseases that are linked to NNMT expression include: Insulin resistance & diabetes Heart disease Kidney disease Liver disease Parkinsons disease Chronic inflammation Im not suggesting that 5-Amino 1MQ will directly lead to reducing your risk of any of the diseases above that time will come when researchers finally smarten up and start testing the peptide in human clinical trials
A PV product is expected to be stable against diverse operational environments under global application scenarios, especially under harsh conditions like extremely high/low temperatures and light soaking
But many of the other peptides you can buy are, at best, experimental, and their purported benefits are unproven
DSIP# DSIP promotes delta-wave sleep through multiple pathways, none of which are fully characterized: Delta wave promotion -- increases the proportion of slow-wave sleep characterized by high-amplitude delta rhythms on EEG, the phenomenon for which it was named Serotonergic and GABAergic modulation -- sleep effects appear to involve modulation of both serotonin and GABA neurotransmission, the two major inhibitory systems involved in sleep initiation and maintenance NMDA receptor modulation -- may influence glutamatergic signaling involved in sleep-wake transitions CRF suppression -- reduces corticotropin-releasing factor, potentially lowering stress-related arousal that prevents sleep onset Neuroendocrine modulation -- affects the release of LH, GH, and ACTH at the hypothalamic level The fundamental distinction is that DSIP's mechanism remains undefined after more than 45 years of research
